Ozempic (semaglutide) is America's most searched drug — and in 2026 the landscape has changed dramatically. The 3-year shortage is officially over. Oral semaglutide tablets are now FDA-approved. Wegovy HD (7.2mg) has launched. And compounded semaglutide has been shut down by the FDA.